Combating the Twin Epidemics of HIV/AIDS and Drug Addiction

  • Date: Tuesday, Mar 4, 2008

    Combating the Twin Epidemics of HIV/AIDS and Drug Addiction:
    Opportunities for Progress and Gaps in Scale

    Presenting Authors:

    Dr. Robert Heimer,Ph.D
    Yale University School of Public Health

    Traci C. Green, M.Sc.
    Yale University School of Public Health

    Discussants:

    Dr. Eric Goosby, M.D.
    CEO and Chief Medical Officer, Pangaea Global AIDS Foundation

    Dr. Caroline Ryan, M.D, M.P.H.
    Office of the U.S. Global AIDS Coordinator

    Moderated by:

    Phillip Nieburg, M.D., M.P.H.
    Senior Associate, CSIS Task Force on HIV/AIDS

    and

    J. Stephen Morrison, Ph.D
    Executive Director, CSIS HIV/AIDS Task Force

    The CSIS report is authored by David A. Fiellin, associate professor of medicine, Department of Internal Medicine, Yale University School of Medicine; Traci C. Green, National Institute on Drug Abuse predoctoral fellow, Yale University School of Public Health; and Robert Heimer, professor, Division of Epidemiology of Microbial Diseases, Yale University School of Public Health.

    Data presented in the report were compiled between November 2006 and June 2007. Sources included papers in the peer-reviewed medical and social science literature, reports from national agencies and international organizations, and direct communication with contacts either in the country of interest or at the agencies and organizations responsible for managing or funding treatment programs and HIV relief efforts.This report focuses on 12 developing countries: 10 with injection-driven HIV epidemics(China, Georgia, Indonesia, Kazakhstan, Kyrgyzstan, Malaysia, Russia,Tajikistan, Ukraine, and Vietnam) and 2 with emerging epidemics among injection drug users (Kenya and Nigeria).

Find More On: